Biologic Patent Landscapes

the orange book for biologics™ we know the patent and regulatory exclusivities protecting hundreds of fda-approved biologics and many in development. about biologic patent landscapes™ patent data is not readily available for biologics—the fda orange book only lists the patents and regulatory exclusivities protecting small-molecule and peptide drugs. biologic patent landscapes was founded to address this critical knowledge gap. who we are biologic patent landscapes is an experienced team of biopharmaceutical patent attorneys in the boston area who have developed algorithms to identify the u.s. patents that actually protect biologic drugs. they continuously verify and update this information and can provide it to you. our clients biopharma companies biopharma patent litigators healthcare payers, distributors, and analysts